Investors

Eastgate Biotech Corp (OTC: ETBI) Management Interview

September 11, 2019 by admin

Eastgate’s new COO took time to discuss his role with the company, ETBI’s licensing strategy, and upcoming goals for the next few months which includes the commencement of the Phase III trial for their flagship product, Insugin.

Read more

EastGate Biotech Announces Appointment of Bill Abajian to Lead Licensing and Marketing Phase as Chief Operating Officer

September 5, 2019 by admin

WEST CALDWELL, NJ and TORONTO, ON /NEWMEDIAWIRE/ September 4, 2019/ EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company, that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, announced today the appointment of distinguished executive Bill Abajian to lead the licensing and marketing phase of the company as Chief Operating Officer of the company, effective August 27, 2019.

Read more

EastGate Biotech Files Application to Initiate Phase III clinical trial for Insugin

June 26, 2019 by admin

Approximately 200 patients will be included in the Phase III study in order to achieve regulatory approval in Pakistan

Read more

Bill Abajian of EastGate Biotech Corp. to speak at the 2019 M&A Forum for Pharma, Biotech and Med Device to be held between August 12 – 14, 2019 in Philadelphia

June 12, 2019 by admin

Forum to focus on Innovative Partnership Opportunities for Product, Porfolio and Market Development

Read more

Link to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer

May 2, 2019 by admin

Link to the interview of Eastgate's CEO Ms. Anna Gluskin.

Read more

EastGate Biotech Announces Positive Phase II Clinical Results of its Innovative Liquid Insulin Mouth Rinse Solution for Type 2 Diabetes

April 24, 2019 by admin

Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day

Read more

Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin

April 10, 2019 by admin

Eastgate BioTech Corp (OTCBB: ETBI) Interview with CEO Anna Gluskin

Read more

https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otc-etbi/

March 25, 2019 by admin

Interview: CEO Anna Gluskin of Eastgate Biotech Corp. (OTC: ETBI)

Read more

Eastgate Biotech Signs Strategic Alliance Agreement with MJ Biopharm for Insulin API Supply

March 19, 2019 by admin

Alliance with MJ Biopharm of Mumbai, India positions the company to further its plans for SEA countries for its liquid insulin mouth rinse

Read more
RSS Icon